Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fondazione del Piemonte per l'Oncologia
National Institutes of Health Clinical Center (CC)
Eastern Cooperative Oncology Group
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Ulsan University Hospital
University of Colorado, Denver
University of Nebraska
EXoPERT
Colorado State University
Orano Med LLC
Pfizer
Var2 Pharmaceuticals
AC Camargo Cancer Center
City of Hope Medical Center
University of Calgary
Washington University School of Medicine
Travera Inc
A2 Biotherapeutics Inc.
Centre Hospitalier de Valence
University of Florida
GONGCHU Biotechnology Co., Ltd
Centre for Research and Technology Hellas
ModeX Therapeutics, An OPKO Health Company
Columbia University
University of Arizona
Institut du Cancer de Montpellier - Val d'Aurelle
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Stanford University
Changhai Hospital
Northwestern University
Chongqing Precision Biotech Co., Ltd
Second Affiliated Hospital of Guangzhou Medical University
Comenius University
Avera McKennan Hospital & University Health Center
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd
Centro di Riferimento Oncologico - Aviano